http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2238947-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 1999-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc26005cc2e14709ad5fe8cfdb4fb5e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4accd63512bc730fae804a9359d1f202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9e19f78575b0c094f89e20ab86dcf8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_794b14cc2965bf49b89c604d55a93186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_803ebbb951dcfe0cfdbf7de37dfcb5b4 |
| publicationDate | 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2238947-C2 |
| titleOfInvention | Human neurotrophic growth factor (enovin), isolated nucleic acid molecule encoding its, vector (variants), pharmaceutical composition (variants), antibody, method for detection of growth factor, set, method for identification of agonist or antagonist (variants) |
| abstract | FIELD: biotechnology, molecular biology, medicine, pharmacy. n SUBSTANCE: invention can be used for preparing the human neurotrophic growth factor (enovin). Isolated nucleic acid molecule is fused into the expressing vector. Vector or the growth factor (enovin) is used for preparing a pharmaceutical composition used for treatment and prophylaxis in disturbances in the nervous system. The growth factor is detected in sample using antibody that is able to bind with the growth factor. Identification of agonist or antagonist of the neurotrophic growth factor is carried out by interaction of biological material expressing the growth factor receptor with the analyzed compound in the presence of the indicated growth factor. Invention provides the development of medicinal agents used or prophylaxis and treatment of neurodegenerative diseases. n EFFECT: improved detecting and identifying methods. n 26 cl, 31 dwg, 4 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2668159-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8247385-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2471487-C2 |
| priorityDate | 1998-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 624.